- Available history
- No dated observations
- Data captured
IPO Date coverage
AKTS IPO Date summary
Aktis Oncology, Inc. (AKTS). What the retained company guidance contains and how many periods can be scored.
| Measure | Value |
|---|---|
| Legal name | Aktis Oncology, Inc. |
| Ticker | AKTS |
| Exchange | Nasdaq |
| IPO date | 9 Jan 2026 |
| Country | United States |
| Final IPO prospectus | Form 424B4 filed 2026-01-09, accession 0001193125-26-009078 |
| Registration statement | Form S-1 filed 2025-12-19, accession 0001193125-25-326780 |